Citations

Clear

367 citation(s) found for "Benson, Al".

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Stearns, Vered , Jegede, Opeyemi A. , Chang, Victor T. , Skaar, Todd C. , Berenberg, Jeffrey L. , Nand, Ranveer , Shafqat, Atif , Jacobs, Nisha L. , Luginbuhl, William , Gilman, Paul , Benson, Al B. , Goodman, Judie R. , Buchschacher, Gary L. , Henry, N. Lynn , Loprinzi, Charles L. , Flynn, Patrick J. , Mitchell, Edith P. , Chang, Victor T-S , Fisch, Michael J , Sparano, Joseph A , Wagner, Lynne , Jagede, Opeyemi A. , Henry, N Lynn , Stearns, Vered , Fisch, Michael , Sparano, Joseph A. , Wagner, Lynne I.

Mayo Clinic

Clinical Cancer Research | April 19, 2024 | Volume: 30 | Issue: 13 | Pages: 2709-2718

10.1158/1078-0432.ccr-23-2137 | PMID 38640040 Get It

Abstract Purpose: Aromatase inhibitor (AI)–associated musculoskeletal symptoms (AIMSS) are common and frequently lead to AI discontinuation. SNPs in candidate genes have been associated with AIMSS and AI discontinuation. E1Z11 is a prospective cohort study designed to validate the association between 10 SNPs and AI discontinuation due to AIMSS. Patients and Methods: Postmenopausal women with stage I to III hormone receptor–positive breast cancer received anastrozole 1 mg daily and completed patient-reported outcome measures to assess AIMSS (Stanford Health Assessment Questionnaire) at baseline, 3, 6, 9, and 12 months. We estimated that 40% of participants would develop AIMSS and 25% would discontinue AI treatment within 12 months. Enrollment of 1,000 women with a fixed number per racial stratum provided 80% power to detect an effect size of 1.5 to 4. SNPs were found in ESR1 (rs2234693, rs2347868, and rs9340835), CYP19A1 (rs1062033 and rs4646), TCL1A (rs11849538, rs2369049, rs7158782, and rs7159713), and HTR2A (rs2296972). Results: Of the 970 evaluable women, 43% developed AIMSS and 12% discontinued AI therapy within 12 months. Although more Black and Asian women developed AIMSS than White women (49% vs. 39%, P = 0.017; 50% vs. 39%, P = 0.004, respectively), the AI discontinuation rates were similar across groups. None of the SNPs were significantly associated with AIMSS or AI discontinuation in the overall population or in distinct cohorts. The OR for rs2296972 (HTR2A) approached significance for developing AIMSS. Conclusions: We were unable to prospectively validate candidate SNPs previously associated with AI discontinuation due to AIMSS. Future analyses will explore additional genetic markers, patient-reported outcome predictors of AIMSS, and differences by race.
Radiology-pathology correlation: Giant tumefactive perivascular spaces
Benson, John C. , Trejo‐Lopez, Jorge , Cormier, Jason L, Mark, Ian T. , Madhavan, Ajay A. , Rydberg, Charlotte H. , Eckel, Laurence J. , Trejo-Lopez, Jorge A, Mark, Ian , Madhavan, Ajay A , Kotsenas, Amy L. , Johnson, Derek R , Benson, John , Parney, Ian F. , Luetmer, Patrick H. , Johnson, Derek R.

Mayo Clinic

The Neuroradiology Journal | April 13, 2024 | Volume: 38 | Issue: 2 | Pages: 233-237

10.1177/19714009241247459 | PMID 38613202 Get It

Dilated perivascular spaces (PVSs) are common and easily recognized on imaging. However, rarer giant tumefactive PVSs (GTPVSs) can have unusual multilocular cystic configurations, and are often confused for other pathologic entities, including neoplasms, cystic infarctions, and neuroepithelial cysts. Because GTPVSs are scarcely encountered and even more infrequently operated upon, many radiologists are unaware of the imaging and pathologic features of these lesions. Here, a case of a resected GTPVS is presented, highlighting both its radiologic and histologic characteristics, and discussing how such lesions can be differentiated from their closest mimickers on imaging.
A review of histopathologic and radiologic features of non-atherosclerotic pathologies of the extracranial carotid arteries
Larson, Anthony S. , Bathla, Girish , Brinjikji, Waleed , Cheek‐Norgan, E. Heidi, Aubry, Marie Christine, Benson, John C. , Cheek-Norgan, Elizabeth Heidi, Aubry, Marie C, Benson, John , Larson, Anthony , Bathla, Girish , Lanzino, Giuseppe , Huston, John

Mayo Clinic

The Neuroradiology Journal | April 1, 2024 | Volume: 37 | Issue: 6 | Pages: 678-687

10.1177/19714009241242592 | PMID 38557110 Get It

Diseases of the carotid arteries can be classified into different categories based on their origin. Atherosclerotic carotid disease remains the most encountered arterial wall pathology. However, other less-common non-atherosclerotic diseases can have detrimental clinical consequences if not appropriately recognized. The underlying histological features of each disease process may result in imaging findings that possess features that are obvious of the disease. However, some carotid disease processes may have histological characteristics that manifest as non-specific radiologic findings. The purpose of this manuscript is to review various non-atherosclerotic causes of carotid artery disease as well as their histologic-radiologic characteristics to aid in the appropriate recognition of these less-commonly encountered pathologies.
Intracranial findings in spontaneous intracranial hypotension: Does the severity of abnormalities correspond with certainty and/or multifocality of cerebrospinal fluid leaks?
Benson, John C. , Mark, Ian T. , Madhavan, Ajay A. , Johnson‐Tesch, Benjamin A., Kim, Dong Kun , Brinjikji, Waleed , Verdoorn, Jared T. , Johnson-Tesch, Benjamin, Diehn, Felix E. , Verdoorn, Jared T , Benson, John , Mark, Ian , Madhavan, Ajay A , Carr, Carrie M.

Mayo Clinic

The Neuroradiology Journal | March 25, 2024 | Volume: 37 | Issue: 4 | Pages: 468-472

10.1177/19714009241242645 | PMID 38525966 Get It

Background and Purpose Spontaneous intracranial hypotension (SIH) is caused by spinal cerebrospinal fluid (CSF) leaks. This study assessed whether the certainty and/or multifocality of CSF leaks is associated with the severity of intracranial sequelae of SIH. Materials and Methods A retrospective review was completed of patients with suspected SIH that underwent digital subtraction myelogram (DSM) preceded by brain MRI. DSMs were evaluated for the presence or absence of a CSF leak, categorized both as positive/negative/indeterminate and single versus multifocal. Brain MRIs were assessed for intracranial sequelae of SIH based on two probabilistic scoring systems (Dobrocky and Mayo methods). For each system, both an absolute “numerical” score (based on tabulation of findings) and “categorized” score (classification of probability) were tabulated. Results 174 patients were included; 113 (64.9%) were female, average age 52.0 ± 14.3 years. One or more definite leaks were noted in 76 (43.7%) patients; an indeterminate leak was noted in 22 (12.6%) patients. 16 (16.3%) had multiple leaks. There was no significant difference in the severity of intracranial findings between patients with a single versus multiple leaks ( p values ranged from .36 to .70 using categorized scores and 0.22–0.99 for numerical scores). Definite leaks were more likely to have both higher categorized intracranial scores (Mayo p = .0008, Dobrocky p = .006) and numerical scores ( p = .0002 for Mayo and p = .006 for Dobrocky). Conclusions Certainty of a CSF leak on diagnostic imaging is associated with severity of intracranial sequelae of SIH, with definite leaks having significantly more intracranial findings than indeterminate leaks. Multifocal leaks do not cause greater intracranial abnormalities.
High yield clinical applications for photon counting CT in neurovascular imaging
Madhavan, Ajay A. , Nagelschneider, Alex A. , Benson, John C. , Diehn, Felix E. , Lehman, Vance T. , Madhavan, Ajay A , Bathla, Girish

Mayo Clinic

British Journal of Radiology | March 10, 2024 | Volume: 97 | Issue: 1157 | Pages: 894-901

10.1093/bjr/tqae058 | PMID 38460543 Get It

Abstract Photon-counting CT (PCCT) uses a novel X-ray detection mechanism that confers many advantages over that used in traditional energy integrating CT. As PCCT becomes more available, it is important to thoroughly understand its benefits and highest yield areas for improvements in diagnosis of various diseases. Based on our early experience, we have identified several areas of neurovascular imaging in which PCCT shows promise. Here, we describe the benefits in diagnosing arterial and venous diseases in the head, neck, and spine. Specifically, we focus on applications in head and neck CT angiography (CTA), spinal CT angiography, and CT myelography for detection of CSF-venous fistulas. Each of these applications highlights the technological advantages of PCCT in neurovascular imaging. Further understanding of these applications will not only benefit institutions incorporating PCCT into their practices but will also help guide future directions for implementation of PCCT for diagnosing other pathologies in neuroimaging.
Prevalence of Scarpa’s ganglion enhancement on high-resolution MRI imaging
Siminski, Clayton , Benson, John C. , Carlson, Matthew L. , Lane, John I. , Benson, John

Mayo Clinic

The Neuroradiology Journal | January 16, 2024 | Volume: 37 | Issue: 3 | Pages: 332-335

10.1177/19714009231224415 | PMID 38226489 Get It

Background and Purpose The vestibular ganglion, or Scarpa’s ganglion, is a cluster of afferent vestibular neurons within the internal auditory canal (IAC). There is minimal literature describing enhancement of this region on magnetic resonance imaging (MRI) and its correlation to clinical symptoms. Here, we sought to find the prevalence of enhancement at Scarpa’s ganglion, and determine whether such enhancement correlates with demographics or clinical symptoms. Materials and Methods A retrospective review was performed of consecutive patients with an MRI of the IAC between 3/1/2021 and 5/20/2021. Two neuroradiologists independently reviewed for T1 and FLAIR enhancement of the Scarpa’s ganglion on post-contrast fat-saturated T1 and post-contrast FLAIR images. Discrepancies were agreed upon by consensus. Clinical variables (hearing loss, vestibular symptoms, tinnitus, and MRI indication) were gathered from a retrospective chart review. Results Eighty-nine patients were included (51 female); the mean age was 58 (range 19–85). The most common MRI indication was hearing loss ( n = 53). FLAIR enhancement was present on the right in 7 patients, on the left in 7 patients, and bilaterally in 6 patients. No enhancement was seen on post-contrast T1 images. There was no statistically significant correlation between consensus FLAIR on at least one side and age ( p = .74), gender ( p = .29), hearing loss ( p = .32), hearing loss side ( p = .39), type of hearing loss ( p = .87), vestibular symptoms ( p = .71), or tinnitus ( p = .81). Conclusions Enhancement is present in the minority of patients on post-contrast FLAIR images. If seen, it should be considered an uncommon but not unexpected finding with no clinical significance.
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program
Braun‐Inglis, Christa , Dressler, Emily V. , Myers, Jamie , Benson, Al B. , Flannery, Marie , Good, Marjorie J. , Denicoff, Andrea , Berenberg, Jeffrey L. , DeTroye, Alisha , O'Brien, Bridget, Kottschade, Lisa A. , Omatsu, Dee Ann, Foust, Melyssa , Lesser, Glenn J. , Braun-Inglis, Christa M , Myers, Jamie S , Good, Marjorie , Kottschade, Lisa A , Nightingale, Chandylen L , Dressler, Emily V , Kittel, Carol , Nightingale, Chandylen L.

Mayo Clinic

JCO Oncology Practice | January 4, 2024 | Volume: 20 | Issue: 2 | Pages: 239-246

10.1200/op.23.00501 | PMID 38175992 Get It

PURPOSE Oncology advanced practice providers (APPs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists, contribute significantly to quality cancer care. Understanding the research-related roles of APPs in the National Cancer Institute's (NCI) Community Oncology Research Program (NCORP) could lead to enhanced protocol development, trial conduct, and accrual. METHODS The 2022 NCORP Landscape Assessment Survey asked two questions about the utilization and roles of APPs in the NCORP. RESULTS A total of 271 practice groups completed the 2022 survey, with a response rate of 90%. Of the 259 nonpediatric exclusive practice groups analyzed in this study, 92% used APPs for clinical care activities and 73% used APPs for research activities. APPs most often provided clinical care for patients enrolled in trials (97%), followed by assistance with coordination (65%), presenting/explaining clinical trials (59%), screening patients (49%), ordering investigational drugs (37%), and consenting participants (24%). Some groups reported APPs as an enrolling investigator (18%) and/or participating in institutional oversight/selection of trials (15%). Only 5% of NCORP sites reported APPs as a site primary investigator for trials, and very few (3%) reported APPs participating in protocol development. CONCLUSION Practice groups report involving APPs in clinical research within the NCORP network; however, opportunities for growth exists. As team-based care has enhanced clinical practice in oncology, this same approach can be used to enhance successful research. Suggested strategies include supporting APP research-related time, recognition, and education. The findings of this survey and subsequent recommendations may be applied to all adult oncology practices that participate in clinical research.